<乌鸦传媒>Hand Cooling, Compression Both Effective for Nerve Pain in Breast Cancer But access, cost, and tolerability may favor the latter option, said researcher Sep 14, 2022
<乌鸦传媒>10-Year Follow-Up Confirms Benefit of Chemoradiotherapy in MIBC Patients Findings "supported a change in clinical practice" Sep 01, 2022
<乌鸦传媒>Hearing Loss Plagues Cancer Survivors No Matter the Type of Chemo Ototoxicity reported in more than half of study patients who got platinum, taxanes, or both Aug 03, 2022
<乌鸦传媒>'Rogue' Online Pharmacies Are Dispensing Cancer Drugs Shady sites with little oversight are selling imatinib for much less than U.S. retail price Jul 29, 2022
<乌鸦传媒>Therapeutic Use of Cannabis: Risks, Benefits, Legality Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
<乌鸦传媒>Liquid Biopsy May Save Colon Cancer Patients From Chemo Circulating tumor DNA could determine who needs more therapy Jun 06, 2022
<乌鸦传媒>Brentuximab Vedotin-Chemo Boosts EFS in High-Risk Pediatric Hodgkin Lymphoma Combo regimen offers "a new standard for front-line therapy," researcher says Jun 04, 2022
<乌鸦传媒>Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients? Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022
<乌鸦传媒>Chemo-ICI Combo Promising in Soft Tissue Sarcoma PFS rate of 69% at 12 weeks in liposarcoma patients with eribulin and pembrolizumab Nov 14, 2021
<乌鸦传媒>The Cost of Blood Platelets Is About to Surge FDA's flawed new guidance for blood transfusion safety takes effect October 1 Sep 30, 2021
<乌鸦传媒>Improved DFS, but No OS Boost, With Chemo in CRC With Liver Metastases Longer disease-free survival did not mean longer overall survival for these patients Sep 28, 2021
<乌鸦传媒>Transarterial Radioembolization Slows Progression of CRC With Liver Mets Small increase in median PFS when combined with second-line chemotherapy Sep 21, 2021
<乌鸦传媒>Androgen-Targeting Combos Show Promise in Prostate Cancer Trials extend survival in hormone-sensitive disease Sep 21, 2021
<乌鸦传媒>Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesothelioma Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
<乌鸦传媒>Could Docetaxel Have Role in Unfavorable-Risk Prostate Cancer? Use of chemo reduced radiation-induced cancers, and may prolong OS in low-PSA subgroup Jul 07, 2021
<乌鸦传媒>Tweaking Maintenance Options in Metastatic CRC Two studies move the needle, but no major breakthroughs Jun 11, 2021
<乌鸦传媒>Perioperative Chemo Enough in Esophageal Cancer? MAGIC/FLOT regimens yielded similar overall survival to multimodal CROSS regimen Jun 06, 2021
<乌鸦传媒>Adding Chemo to Standard Care No Help for Cervical Cancer Similar OS, PFS, and patterns of recurrence, with more toxicity Jun 04, 2021
<乌鸦传媒>PD-L1 Inhibitor Thwarts Recurrence in Early Lung Cancer Risk of death, recurrence 34% lower with atezolizumab after surgery and chemo May 19, 2021
<乌鸦传媒>What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
<乌鸦传媒>New Clues to Sleep Problems, Solutions in Cancer Patients Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
<乌鸦传媒>What to Do With a Rare, Aggressive Bladder Cancer Case authors lament scant information on treatments or outcomes Apr 26, 2021
<乌鸦传媒>Chemotherapy Nausea Linked to Stress, Neuropsych Symptoms High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
<乌鸦传媒>Auricular Acupressure May Relieve Neuropathy in Breast Cancer First randomized trial of the noninvasive technique in such patients Apr 22, 2021
<乌鸦传媒>More Benefit With Taxane for Aggressive Metastatic Prostate Cancer Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
<乌鸦传媒>Triple-Negative Breast Cancers Not All the Same Histology tied to treatment response, outcomes Apr 12, 2021
<乌鸦传媒>Anti-PD-L1 Flops in Locally Advanced Head and Neck Cancer No PFS benefit from adding avelumab to chemoradiation, hazard ratio favored placebo Apr 02, 2021
<乌鸦传媒>HIPEC Combo Doubles PFS in Advanced Ovarian Cancer Cisplatin/paclitaxel boosts outcomes without increasing complications in registry study Mar 26, 2021
<乌鸦传媒>Little Benefit With Adjuvant Therapy for High-Risk Endometrial Cancer Chemo prevented relapse but did not improve survival, no benefit from radiotherapy Mar 23, 2021
<乌鸦传媒>Practice-Changing Trial in Second-Line Endometrial Cancer Pembrolizumab plus lenvatinib improved median OS by nearly 7 months versus chemotherapy Mar 19, 2021
<乌鸦传媒>New Drug OK'd for Chemo-Induced Myelosuppression in SCLC CDK4/6 inhibitor cut the risk for severe neutropenia in small-cell lung cancer patients Feb 13, 2021
<乌鸦传媒>Survival Boost in Bladder Cancer With Antibody-Drug Conjugate Four-month absolute improvement with enfortumab vedotin in previously treated disease Feb 12, 2021
<乌鸦传媒>Anti-CD20 Drugs Tied to Severe COVID in Cancer Patients Plus: Active chemo treatment may not be a COVID risk factor Feb 05, 2021
<乌鸦传媒>Optimizing Neoadjuvant Therapy for Breast Cancer ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
<乌鸦传媒>Dustin Diamond's Small Cell Lung Cancer "Saved by the Bell" actor diagnosed after exhaustive testing Feb 02, 2021
<乌鸦传媒>KRAS Inhibitor Continues to Impress in NSCLC Sotorasib yielded deep and durable responses in over one-third of patients Feb 01, 2021
<乌鸦传媒>Nab-Paclitaxel as Possible Option for Relapsed NSCLC Noninferior to docetaxel for OS, though impact on clinical practice questioned Feb 01, 2021
<乌鸦传媒>Should COVID-Strained Centers Hit Pause on Lung Cancer Screening? A debate on what stopping scans would do to health systems, patients Feb 01, 2021
<乌鸦传媒>Montana Oncologist Fired for Misdiagnosing, Overtreating Patients But some rally around him Jan 26, 2021
<乌鸦传媒>Preop RT Flunks Test in Borderline Pancreatic Cancer Chemotherapy alone judged efficacious but not chemoradiation Jan 20, 2021
